Gene therapy for PID: The end of the beginning?

Abstract

In this issue of Blood, Cicalese and colleagues report excellent medium-term survival and immune reconstitution outcomes for patients with adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) treated with a retroviral gene vector.